{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:50:49Z","timestamp":1789735849116,"version":"4.0.1"},"reference-count":11,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":12145,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1982,6]]},"DOI":"10.1111\/j.1445-5994.1982.tb02485.x","type":"journal-article","created":{"date-parts":[[2008,3,25]],"date-time":"2008-03-25T12:10:36Z","timestamp":1206447036000},"page":"303-304","source":"Crossref","is-referenced-by-count":38,"title":["TOPICAL BIOAVAILABILITY OF METHYL SALICYLATE"],"prefix":"10.1111","volume":"12","author":[{"given":"M. S.","family":"ROBERTS","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. A.","family":"FAVRETTO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"MEYER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"RECKMANN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"WONGSEELASHOTE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,3,25]]},"reference":[{"key":"10.1111\/j.1445-5994.1982.tb02485.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1378\/chest.76.6.640","article-title":"Haemodynamic and metabolic responses to upright exercise in patients with congestive heart failure: treatment with nitroglycerin ointment","volume":"76","author":"Moskowiu","year":"1979","journal-title":"Chest"},{"key":"10.1111\/j.1445-5994.1982.tb02485.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/03602537808993785","article-title":"Controlled topical delivery of drugs for systemic action","volume":"8","author":"Shaw","year":"1978","journal-title":"Drug Mclab Rev"},{"key":"10.1111\/j.1445-5994.1982.tb02485.x-BIB3|cit3","first-page":"32","article-title":"The absorption of methyl salicylate bv the human skin","volume":"50","author":"Brown","year":"1934","journal-title":"J Pharmacol Exp Thcr"},{"key":"10.1111\/j.1445-5994.1982.tb02485.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/jps.2600500403","article-title":"Investigation of some factors influencing percutaneous absorption","volume":"50","author":"Wurster","year":"1961","journal-title":"J Pharm Sci"},{"key":"10.1111\/j.1445-5994.1982.tb02485.x-BIB5|cit5","first-page":"207","article-title":"On the metabolism and toxicity of methyl salicylate","volume":"132","author":"Davison","year":"1961","journal-title":"J Pharmacol Exp Thcr"},{"key":"10.1111\/j.1445-5994.1982.tb02485.x-BIB6|cit6","first-page":"95","article-title":"The availability of sodium salicylate from enteric coated tablets","volume":"NS3","author":"Page","year":"1974","journal-title":"Aust J Pharm Sci"},{"key":"10.1111\/j.1445-5994.1982.tb02485.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/jps.2600650934","article-title":"Pharmacokinetics of skin penetration","volume":"65","author":"Cooper","year":"1976","journal-title":"J Pharm Sci"},{"key":"10.1111\/j.1445-5994.1982.tb02485.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2165\/00003088-198005050-00002","article-title":"Monitoring plasma concentrations of salicylate","volume":"5","author":"Mandelli","year":"1980","journal-title":"Clin Pharmacokinct"},{"key":"10.1111\/j.1445-5994.1982.tb02485.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/jps.2600570807","article-title":"Pharmacokinetics of acctylsalicylie acid and salicylic acid after intravenous administration in man","volume":"57","author":"Rowland","year":"1968","journal-title":"J Pharm Sci"},{"key":"10.1111\/j.1445-5994.1982.tb02485.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/cpt1979263380","article-title":"Salicylate clearance, the resultant of protein binding and metabolism","volume":"26","author":"Furst","year":"1979","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1445-5994.1982.tb02485.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/jps.2600640604","article-title":"Percutaneous absorption","volume":"64","author":"Idson","year":"1975","journal-title":"J Pharm Sci"}],"container-title":["Australian and New Zealand Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1445-5994.1982.tb02485.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1445-5994.1982.tb02485.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T09:07:31Z","timestamp":1625648851000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1445-5994.1982.tb02485.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982,6]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1982,6]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1445-5994.1982.tb02485.x","relation":{},"ISSN":["0004-8291"],"issn-type":[{"value":"0004-8291","type":"print"}],"subject":[],"published":{"date-parts":[[1982,6]]}}}